Lindbrook Capital’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Lindbrook Capital’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-495	Closed	-$21.1K	–	2853
2023 Q2	$20.9K	Buy	495 +258	+109%	+$10.4K	﹤0.01%	1067
2023 Q1	$8.44K	Sell	237 -532	-69%	-$19.3K	﹤0.01%	1558
2022 Q4	$28.2K	Buy	769 +692	+899%	+$27.4K	﹤0.01%	907
2022 Q3	$4K	Buy	77 +3	+4%	+$194	﹤0.01%	1815
2022 Q2	$5K	Buy	74 +14	+23%	+$1.02K	﹤0.01%	1592
2022 Q1	$5K	Hold	60	–	–	﹤0.01%	1644
2021 Q4	$6K	Buy	+60	New	+$5.76K	﹤0.01%	1476

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Lindbrook Capital's SYNH Position: Q3 2023 in Review

Lindbrook Capital sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 495 shares — an estimated $21.1K sold.

Lindbrook Capital first reported a position in SYNH in Q4 2021 and held it in 7 quarters. The position peaked at $28.2K in Q4 2022. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

Lindbrook Capital reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Lindbrook Capital sold 495 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $21.1K.
Lindbrook Capital first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2021 and held it in 7 quarters.
Lindbrook Capital's Syneos Health, Inc. Class A Common Stock position peaked at $28.2K in Q4 2022.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Lindbrook Capital's 13F filing for Q3 2023, filed 25 Oct 2023.